PHC Corporation develops, manufactures, and sells a variety of life sciences and diagnostic solutions. Our offerings include research and medical support equipment such as ultra-low temperature freezers and CO2 incubators; innovative solutions for the cell and gene therapy (CGT) field, including our live cell metabolic analyzer; testing and analysis devices, including point-of-care testing (POCT) equipment, and in vitro diagnostic reagents. We contribute to improving the accuracy and efficiency of healthcare and life science research in 110 countries and regions by providing precision technology that seeks to improve lives.
View All
2026.3.30
Announcement of Changes in Board Members at PHC Corporation Effective April 1, 2026
2026.3.2
PHCbi Launches LiCellGrow™ Cell Expansion System to Support High-Quality and Efficient Production of Cell and Gene Therapies — Proprietary In-Line Monitoring Technology Enables Seamless Scale-Up from Basic Research to Commercial Manufacturing —
2025.9.1
PHC and JCR GROWJECTOR® L Automated Injection Device Wins 2025 Kids Design Award
2025.8.29
PHC Corporation’s Biomedical Division Wins 2025 R&D 100 Award for LiCellMo® Live Cell Metabolic Pathway Analyzer